Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...

VAS-101, a curcumin-based gel for SCD, was well tolerated and showed signs of easing sickle cell pain, fatigue, and red blood ...

Mutations in the HBB gene cause SCD by leading to the production of a faulty version of hemoglobin (the protein that helps red blood cells transport oxygen), which tends to clump inside red blood ...

A vaso-occlusive crisis (VOC), a hallmark of sickle cell disease (SCD), is an episode of intense pain related to blood vessel blockage and a lack of oxygen supply. In SCD, genetic mutations lead to ...

The causes of sickle cell disease (SCD), an inherited blood disorder, are related to hemoglobin, a protein that helps red blood cells carry oxygen throughout the body. People with sickle cell have ...

When good specialists from a healthcare team move on, it can disrupt a patient's world, writes columnist Mary Shaniqua. But ...

A $1.9-million federal grant has been awarded to a clinical trial that seeks to find effective ways to improve adherence to hydroxyurea treatment among children and young adults with sickle cell ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Although approximately 1 in 6 people worldwide are living with a ...